1. A prospective, randomized, three arm, open label study comparing the safety and efficacy of PP110, a novel treatment for hemorrhoids to preparation-H® maximum strength cream in the treatment of grade 2–3 hemorrhoids. Issue 1 (December 2015) Authors: Klein, Ehud; Shapiro, Ron; Ben-Dahan, Jose; Simcha, Moshe; Azuri, Yosef; Rosen, Ada Journal: Molecular and cellular therapies Issue: Volume 3:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AAV-mediated NT-3 overexpression protects cochleae against noise-induced synaptopathy. Issue 4 (July 2018) Authors: Chen, Hengchao; Xing, Yazhi; Xia, Li; Chen, Zhengnong; Yin, Shankai; Wang, Jian Journal: Gene therapy Issue: Volume 25:Issue 4(2018) Page Start: 251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AAV1.NT-3 gene therapy increases muscle fiber diameter through activation of mTOR pathway and metabolic remodeling in a CMT mouse model. Issue 2 (April 2018) Authors: Yalvac, Mehmet; Amornvit, Jakkrit; Chen, Lei; Shontz, Kimberly; Lewis, Sarah; Sahenk, Zarife Journal: Gene therapy Issue: Volume 25:Issue 2(2018) Page Start: 129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Albumin-based drug delivery: harnessing nature to cure disease. Issue 1 (December 2016) Authors: Larsen, Maja; Kuhlmann, Matthias; Hvam, Michael; Howard, Kenneth Journal: Molecular and cellular therapies Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Albumin-based drug delivery: harnessing nature to cure disease. Issue 1 (December 2016) Authors: Larsen, Maja; Kuhlmann, Matthias; Hvam, Michael; Howard, Kenneth Journal: Molecular and cellular therapies Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. An important step on the long path to clinical application of in utero gene therapy. Issue 7 (October 2018) Authors: Coutelle, Charles Journal: Gene therapy Issue: Volume 25:Issue 7(2018) Page Start: 451 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Anti-angiogenic treatment of endometriosis via anti-VEGFA siRNA delivery by means of peptide-based carrier in a rat subcutaneous model. Issue 8 (December 2018) Authors: Egorova, Anna; Petrosyan, Mariya; Maretina, Marianna; Balashova, Natalia; Polyanskih, Lyudmila; Baranov, Vladislav; Kiselev, Anton Journal: Gene therapy Issue: Volume 25:Issue 8(2018) Page Start: 548 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. CAR-T in the clinic: drive with care. Issue 3 (June 2018) Authors: Yáñez-Muñoz, Rafael; Grupp, Stephan Journal: Gene therapy Issue: Volume 25:Issue 3(2018) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. CAR-T: trailblazing the path from clinical development to the clinic. Issue 3 (June 2018) Authors: Butera, Samuele Journal: Gene therapy Issue: Volume 25:Issue 3(2018) Page Start: 163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Downreguation of FoxM1 by miR-214 inhibits proliferation and migration in hepatocellular carcinoma. Issue 4 (July 2018) Authors: Tian, Chuan; Wu, Haixia; Li, Chan; Tian, Xia; Sun, Yong; Liu, Enqiang; Liao, Xiuyong; Song, Wei Journal: Gene therapy Issue: Volume 25:Issue 4(2018) Page Start: 312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗